NCT07473128 2026-03-16
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Pharmacosmos A/S
Phase 3 Not yet recruiting
Pharmacosmos A/S
Merck Sharp & Dohme LLC
Ciusss de L'Est de l'Île de Montréal
EMD Serono
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Merck KGaA, Darmstadt, Germany
Instituto Nacional de Cancer, Brazil